What does CUSIP 23255M105 represent in this 13F holders report?

CUSIP 23255M105 is the security identifier for CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK used to aggregate holder disclosures.

How many institutions held CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in Q1 2019?

3 institutional investors reported CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK for Q1 2019. Use the holders table for investor-level position and value details.

CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN)

CUSIP: 23255M105

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / COMMON STOCK
Shares outstanding: 4,330,313
Total 13F shares: 855,056
Share change: +854,759
Total reported value: $12,666,000
Price per share: $15.13
Number of holders: 3
Value change: +$12,665,000
Number of buys: 2

Quarterly Holders Quick Answers

What is CUSIP 23255M105?
CUSIP 23255M105 identifies CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2019

Recent filing periods for CUSIP 23255M105:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022

Top shareholders of CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) as of Q1 2019

As of 31 Mar 2019, CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 855,056 shares. The largest 3 holders included FARALLON CAPITAL MANAGEMENT LLC, NORTHERN TRUST CORP, and CWM, LLC. This page lists 3 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2019 vs Q3 2023 Across Filers

Q3 2023 holders

Q1 2019 holders

Holder diff

Investor	Q3 2023 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q1 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.